EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Herpetic reactivation during radiotherapy treatment for gynaecological cancers—a retrospective observational study

Deepu C Tom, Avinash H Udayashankara iD, Nirmala S, Hadrian Noel Alexander F, Jayalekshmi R, Sakshi Garg, John Michael Raj

Supportive Care in Cancer · 2026-09 · 34 (9)

DOI: 10.1007/s00520-026-11152-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 28.08.2026. Verfasst von Deepu C Tom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, St. John's Medical College, Bengaluru, Karnataka, 560034, India. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Herpes Simplex, Herpes Zoster, Simplexvirus. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Herpes simplex virus (HSV) and varicella zoster virus (VZV) remain latent in sensory ganglia and can reactivate under immunosuppressive states such as cancer therapy. Radiotherapy-induced local immune suppression may increase the risk of herpes reactivation, leading to treatment interruptions and suboptimal outcomes. Evidence on the incidence and determinants of herpes reactivation among gynaecologic cancer patients undergoing radiotherapy remains limited. METHODS: A retrospective observational study was conducted at St. John's Medical College Hospital, including women ≥ 18 years with histologically confirmed gynaecologic malignancies treated with definitive or adjuvant radiotherapy between January 2016 and October 2025. Demographic, clinical, treatment-related characteristics, and comorbidities were analyzed. The study aimed to determine the incidence of HSV/VZV reactivation during radiotherapy, evaluate associated risk factors. RESULTS: Among 391 patients analyzed, herpes reactivation occurred in 5.6% (22 patients). All reactivations occurred in patients with carcinoma of uterine cervix (7.6% (22/291); p = 0.018), with no HRA in other gynaecologic cancers. Higher EBRT dose (p = 0.020), use of VMAT/IMRT techniques (p = 0.008), concurrent chemotherapy (8.1% vs 0%, p = 0.002) and presence of STIs (Sexually Transmitted Infections) (27.8% (5/18) versus 4.6% (17/373); p < 0.001) were associated with significantly increased risk. Interestingly, the patients treated post COVID 19 pandemic were more likely to develop reactivation that those treated before pandemic (8.8% vs 1.7%; p = 0.002). 53.3% of the treatment interruptions were attributable to HRAs. CONCLUSION: Herpes virus reactivation during radiotherapy for gynecologic cancers is a significant cause of treatment interruption. Carcinoma uterine cervix and presence of other STIs are significant risk factors. There is higher incidence of reactivations in the post COVID era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemaleHerpes SimplexHerpes ZosterSimplexvirusVirus ActivationAdultAgedAged, 80 and overFemaleHumansMiddle AgedHerpesvirus 3, HumanIncidenceRetrospective StudiesRisk FactorsIndia

Stichwörter der Autor:innen

COVID-19Gynaecologic cancersHerpes simplexHerpes zosterHerpetic reactivationRadiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, St. John's Medical College, Bengaluru, Karnataka, 560034, India.
  • Department of Radiation Oncology, St. John's Medical College, Bengaluru, Karnataka, 560034, India. avinash.hu@gmail.com.
  • Department of Biostatistics, St. John's Medical College, Bengaluru, Karnataka, 560034, India.

ORCID-Profile: Avinash H Udayashankara

Zitieren

APA

Tom, D. C., Udayashankara, A. H., S, N., F, H. N. A., R, J., Garg, S., & Raj, J. M. (2026). Herpetic reactivation during radiotherapy treatment for gynaecological cancers—a retrospective observational study. Supportive Care in Cancer, 34(9). https://doi.org/10.1007/s00520-026-11152-5

Vancouver

Tom DC, Udayashankara AH, S N, F HNA, R J, Garg S, et al. Herpetic reactivation during radiotherapy treatment for gynaecological cancers—a retrospective observational study. Supportive Care in Cancer. 2026;34(9). doi:10.1007/s00520-026-11152-5

BibTeX
@article{Tom2026,
  author = {Tom, Deepu C and Udayashankara, Avinash H and S, Nirmala and F, Hadrian Noel Alexander and R, Jayalekshmi and Garg, Sakshi and Raj, John Michael},
  title = {Herpetic reactivation during radiotherapy treatment for gynaecological cancers—a retrospective observational study},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {9},
  doi = {10.1007/s00520-026-11152-5}
}
Kostenlos starten →